Insider Buying: IXICO plc (LON:IXI) Insider Purchases 45,263 Shares of Stock

IXICO plc (LON:IXI) insider Grant Nash bought 45,263 shares of the firm’s stock in a transaction on Thursday, June 12th. The stock was acquired at an average cost of GBX 13 ($0.18) per share, with a total value of £5,884.19 ($8,011.15).

IXICO Stock Performance

Shares of LON IXI opened at GBX 11.85 ($0.16) on Friday. The firm’s 50-day moving average price is GBX 9.86 and its 200-day moving average price is GBX 10.56. IXICO plc has a 52-week low of GBX 6.45 ($0.09) and a 52-week high of GBX 15 ($0.20). The company has a market cap of £10.98 million, a PE ratio of -3.07, a PEG ratio of -0.38 and a beta of 0.86. The company has a quick ratio of 4.90, a current ratio of 2.85 and a debt-to-equity ratio of 3.32.

IXICO (LON:IXI) last issued its earnings results on Tuesday, May 20th. The company reported GBX (1.11) (($0.02)) earnings per share (EPS) for the quarter. IXICO had a negative return on equity of 19.14% and a negative net margin of 31.10%. As a group, analysts anticipate that IXICO plc will post -289.3584879 EPS for the current year.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.